United States
Independent
Lundbeck v. Commission, reverse payments, pay for delay, patent settlements, pharmaceuticals, European competition law, Article 101 TFEU, restriction by object, intellectual property, antitrust, FTC v. Actavis
reverse payments, pay for delay, generics, patent settlements, pharmaceuticals, European competition law, Article 101 TFEU, Article 102 TFEU, restriction by object, restriction by effect, abuse of dominance, intellectual property, antitrust
FTC v. Actavis, reverse payment, pay for delay, settlements, antitrust, pharmaceuticals, patent litigation, Effexor XR, authorized generics, European Competition Law, Lundbeck, Commission
reverse payments, pay for delay, settlements, antitrust, pharmaceuticals, patent litigation, 101 TFEU, side deals, generics, European Competition Law, Servier, Paroxetine, Commission
product reformulations, product hopping, antitrust, competition, 101 TFEU, pay-for-delay, generic entry, innovation, pharmaceuticals
